Cancer screening methods have also seen a transformation. There is an increasing demand for non-invasive and more accurate screening tools. For example, liquid biopsies, which analyze circulating tumor DNA in the blood, are becoming more popular as they offer a less invasive alternative to traditional tissue biopsies. Additionally, patients are becoming more proactive in seeking early detection methods, which can significantly improve prognosis.
